$5.40
-1.62-23.08%
At close: -
$5.42
0.020.37%
After Hours: 4:27 PM EDT
Comments
Loading...
Zhengye Biotechnology Analyst Ratings and Price Targets | NASDAQ:ZYBT | Benzinga
Zhengye Biotechnology Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Zhengye Biotechnology Corp from these most-recent analyst ratings.
Analyst Ratings for Zhengye Biotechnology
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Zhengye Biotechnology (ZYBT) stock?
There is no price target for Zhengye Biotechnology
What is the most recent analyst rating for Zhengye Biotechnology (ZYBT)?
There is no analyst for Zhengye Biotechnology
When was the last upgrade for Zhengye Biotechnology (ZYBT)?
There is no last upgrade for Zhengye Biotechnology
When was the last downgrade for Zhengye Biotechnology (ZYBT)?
There is no last downgrade for Zhengye Biotechnology.
When is the next analyst rating going to be posted or updated for Zhengye Biotechnology (ZYBT)?
There is no next analyst rating for Zhengye Biotechnology.
Is the Analyst Rating Zhengye Biotechnology (ZYBT) correct?
There is no next analyst rating for Zhengye Biotechnology.
Browse analyst ratings and price targets on all stocks.